Combination therapy for scleroderma associated pulmonary arterial hypertension
Peter Kabunga, JG Coghlan(Royal Free London NHS Foundation Trust), CE Handler, David Bloore, Chandan Das(Indian Institute of Technology Guwahati), Florenc Vrapi, Casilda G. Black, CP Denton(The Royal Free Hospital), Carol Smith
UCL Discovery (University College London)
June 1, 2007
Cited by 0
Related Papers
Prevalence and outcome in systemic sclerosis associated pulmonary arterial hypertension: application of a registry approach
|Annals of the Rheumatic Diseases|2003|769
Bosentan treatment of digital ulcers related to systemic sclerosis: results from the RAPIDS-2 randomised, double-blind, placebo-controlled trial
|Annals of the Rheumatic Diseases|2010|503
Open-Label Trial of Anti-TNF-α in Dermato- and Polymyositis Treated Concomitantly with Methotrexate
|European Neurology|2008|99
Submaximal exercise testing in the assessment of interstitial lung disease secondary to systemic sclerosis: reproducibility and correlations of the 6-min walk test
|Annals of the Rheumatic Diseases|2006|98